Information
-
Trademark
-
88064933
-
Serial Number
88064933
-
Registration Number
6021542
-
International Classifications
-
Filing Date
August 03, 2018
6 years ago
-
Registration Date
March 31, 2020
4 years ago
-
Transaction Date
January 06, 2021
3 years ago
-
Status Date
March 31, 2020
4 years ago
-
Published for Opposition Date
January 14, 2020
4 years ago
-
Location Date
March 31, 2020
4 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
KEATING, MICHAEL P
-
Attorney Docket Number
13318.1006US
Attorney Name
Scott D. Marty, JD, PhD
Law Office Assigned Location Code
L10
-
Owners
Mark Drawing Code
3000
Mark Identification
HEIDELBERG PHARMA
Case File Statements
- CC0000: The color(s) blue and light blue is/are claimed as a feature of the mark.
- D10000: "PHARMA"
- DM0000: The mark consists of a blue circle within another light blue partial circular design, to the right of which appears the stylized word "Heidelberg" in blue letters. Appearing within the partial circular design, and under the word "Heidelberg" is the stylized word "PHARMA" in blue upper-case letters.
- GS0011: Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
- GS0051: Pharmaceutical preparations for the treatment of immuno oncological disorders, namely, cancer; pharmaceuticals for cancer therapy; chemico-pharmaceutical preparations for cancer therapies; pharmaceutical preparations and substances for use in the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer; pharmaceutical preparations for human use, namely, for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic agents for medical use; clinical diagnostic reagents; diagnostic chemical reagents for medical use; anti-cancer drugs; compounds for treating cancer; anti-cancer preparations; anti-cancer preparations of chemical origin; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; chemotherapeutics; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing
- GS0421: Pharmaceutical research services; medical and pharmacological research services; pharmaceutical products development; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; scientific research; medical research; biomedical research services; research relating to biotechnology; research on the subject of pharmaceuticals; consultancy relating to research in the field of pharmacogenetics; research and development in the pharmaceutical and biotechnology fields; research and development in the field of diagnostic preparations; research and development in the field of biotechnology; research and development for the pharmaceutical industry; research and development services in the field of antibody technology; research and development services in the field of antibodies; laboratory services relating to the production of monoclonal antibodies
- GS0441: Pharmaceutical advice; pharmaceutical services, namely, providing pharmaceutical advice and consultation and dispensing drugs to patients with cancer; consultancy and medical information services relating to pharmaceutical products
- TF0000: As to "HEIDELBERG PHARMA"
Case File Event Statements
-
1/5/2021 - 3 years ago
31 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
1/5/2021 - 3 years ago
30 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
1/5/2021 - 3 years ago
29 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
1/5/2021 - 3 years ago
28 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
1/5/2021 - 3 years ago
27 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
3/31/2020 - 4 years ago
26 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
1/14/2020 - 4 years ago
25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
1/14/2020 - 4 years ago
24 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
12/25/2019 - 4 years ago
23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
12/12/2019 - 4 years ago
22 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
12/12/2019 - 4 years ago
21 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
12/12/2019 - 4 years ago
20 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
12/12/2019 - 4 years ago
19 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
12/12/2019 - 4 years ago
18 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
11/18/2019 - 4 years ago
17 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
11/18/2019 - 4 years ago
16 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
11/16/2019 - 4 years ago
15 - ASSIGNED TO LIE
Type: ALIE
-
11/11/2019 - 4 years ago
14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
5/9/2019 - 5 years ago
13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
5/9/2019 - 5 years ago
12 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
5/9/2019 - 5 years ago
11 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
4/26/2019 - 5 years ago
10 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
4/26/2019 - 5 years ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
4/26/2019 - 5 years ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
11/26/2018 - 5 years ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
11/26/2018 - 5 years ago
6 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
11/26/2018 - 5 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
11/21/2018 - 5 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
8/10/2018 - 6 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
8/9/2018 - 6 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
8/7/2018 - 6 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP